Locations:
SearchAdvertisement
Despite sicker patients, response rates of teclistamab in a real-world study were similar to those from a pivotal clinical trial
Investigational chimeric antigen receptor natural killer cell therapy NKX101 associated with promising early response in patients with relapsed/refractory acute myeloid leukemia
San Antonio Breast Cancer Symposium presentations underscore safety of assisted reproductive technology and pregnancy in women during and after breast cancer treatment
Study offers a foundation for additional research to examine radiation and immune response
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic oncologists’ selected abstracts
Multidisciplinary care for patients with immune-related adverse events
Researchers compared tacrolimus/methotrexate to tacrolimus and reduced-dose methotrexate/mycophenolate
Correlation found between the biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy
Newer medications pivotal for improving gastrointestinal symptoms in patients with cancer
Cleveland Clinic radiation oncologists aim to bring the noninvasive approach back to the U.S., where use has declined
Advertisement
Advertisement